Please use this identifier to cite or link to this item:
|Title:||Pharmacologically induced angiogenesis in transgenic zebrafish||Authors:||Raghunath, M.
Sy Wong, Y.
Prolyl hydroxylase inhibitors
|Issue Date:||23-Jan-2009||Citation:||Raghunath, M., Sy Wong, Y., Farooq, M., Ge, R. (2009-01-23). Pharmacologically induced angiogenesis in transgenic zebrafish. Biochemical and Biophysical Research Communications 378 (4) : 766-771. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bbrc.2008.11.127||Abstract:||The rapid vascularisation of biomaterials and engineered tissue after implantation is a current unmet need. To this end, we explored the pharmacological option of inducing neovascularisation using compounds that inhibit hypoxia-induced factor-1α prolyl hydroxylase. This stabilises hypoxia inducible factor-1α and therefore de-repress the transcription of various angiogenic genes. In the quest for a small vertebrate model allowing for in vivo screening we exposed (TG(Fli1:EGFP)) transgenic zebrafish embryos exhibiting fluorescent blood vessels to hydralazine hydrochloride and 2,4-pyridine dicarboxylic acid from 6 hpf to 72 hpf by immersion. Live observation of embryos revealed that the substances induced formation of ectopic blood vessels in the subintestinal vessel basket. We confirmed the HIF-stabilising effects biochemically in human fibroblasts and with an in vitro angiogenesis fibroblast/HUVEC co-culture model. Cross-inhibition of collagen prolyl hydroxylase was confirmed by reduced collagen secretion by fibroblasts and reduced collagen content of zebrafish embryos. © 2008 Elsevier Inc. All rights reserved.||Source Title:||Biochemical and Biophysical Research Communications||URI:||http://scholarbank.nus.edu.sg/handle/10635/67216||ISSN:||0006291X||DOI:||10.1016/j.bbrc.2008.11.127|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.